A cost-consequences analysis of an adherence focused pharmacist-led medication review service
A cost-consequences analysis of an adherence focused pharmacist-led medication review service
OBJECTIVES: The aim of this project was to conduct an economic evaluation of the Norfolk Medicines Support Service (NMSS), a pharmacist-led medication review service for patients identified in primary care as non-adherent.
METHODS: The cost-consequences analysis was based on a before and after evaluation of the NMSS. Participants completed a self-reported adherence and health-related quality of life questionnaire prior to the review, at 6 weeks and 6 months. Service provision, prescribing and secondary care costs were considered and the mean cost before and after the intervention was calculated.
KEY FINDINGS: One-hundred and seventeen patients were included in the evaluation. The mean cost per patient of prescribing and hospital admissions in the 6 months prior to the intervention was £2190 and in the 6 months after intervention £1883. This equates to a mean cost saving of £307 per patient (parametric 95% confidence interval: £1269 to £655). The intervention reduced emergency hospital admissions and increased medication adherence but no significant change in health-related quality of life was observed.
CONCLUSION: The costs of providing this medication review service were offset by the reduction in emergency hospital admissions and savings in medication cost, assuming the findings of the evaluation were real and the regression to the mean phenomenon was not involved. This cost-consequences approach provides a transparent descriptive summary for decision-makers to use as the basis for resource allocation decisions.
Aged, Cost Savings, Cost-Benefit Analysis, Drug Costs, Emergency Service, Hospital/economics, Follow-Up Studies, Hospitalization/economics, Humans, Medication Adherence, Pharmaceutical Services/economics, Pharmacists/economics, Prescription Drugs/administration & dosage, Primary Health Care/economics, Professional Role, Quality of Life, Surveys and Questionnaires
41-9
Desborough, James A
5ec7cf8c-01fe-40ab-ba59-2ffa7057be46
Sach, Tracey
5c09256f-ebed-4d14-853a-181f6c92d6f2
Bhattacharya, Debi
2b54406d-469b-4a79-989c-be3b2f5cde2e
Holland, Richard C
910f8dc0-f653-4437-95f7-c0d513d88a80
Wright, David J
a55be721-4b15-4555-bf61-73fcb75c1a39
February 2012
Desborough, James A
5ec7cf8c-01fe-40ab-ba59-2ffa7057be46
Sach, Tracey
5c09256f-ebed-4d14-853a-181f6c92d6f2
Bhattacharya, Debi
2b54406d-469b-4a79-989c-be3b2f5cde2e
Holland, Richard C
910f8dc0-f653-4437-95f7-c0d513d88a80
Wright, David J
a55be721-4b15-4555-bf61-73fcb75c1a39
Desborough, James A, Sach, Tracey, Bhattacharya, Debi, Holland, Richard C and Wright, David J
(2012)
A cost-consequences analysis of an adherence focused pharmacist-led medication review service.
International Journal of Pharmacy Practice, 20 (1), .
(doi:10.1111/j.2042-7174.2011.00161.x).
Abstract
OBJECTIVES: The aim of this project was to conduct an economic evaluation of the Norfolk Medicines Support Service (NMSS), a pharmacist-led medication review service for patients identified in primary care as non-adherent.
METHODS: The cost-consequences analysis was based on a before and after evaluation of the NMSS. Participants completed a self-reported adherence and health-related quality of life questionnaire prior to the review, at 6 weeks and 6 months. Service provision, prescribing and secondary care costs were considered and the mean cost before and after the intervention was calculated.
KEY FINDINGS: One-hundred and seventeen patients were included in the evaluation. The mean cost per patient of prescribing and hospital admissions in the 6 months prior to the intervention was £2190 and in the 6 months after intervention £1883. This equates to a mean cost saving of £307 per patient (parametric 95% confidence interval: £1269 to £655). The intervention reduced emergency hospital admissions and increased medication adherence but no significant change in health-related quality of life was observed.
CONCLUSION: The costs of providing this medication review service were offset by the reduction in emergency hospital admissions and savings in medication cost, assuming the findings of the evaluation were real and the regression to the mean phenomenon was not involved. This cost-consequences approach provides a transparent descriptive summary for decision-makers to use as the basis for resource allocation decisions.
This record has no associated files available for download.
More information
Published date: February 2012
Additional Information:
© 2011 The Authors. IJPP © 2011 Royal Pharmaceutical Society.
Keywords:
Aged, Cost Savings, Cost-Benefit Analysis, Drug Costs, Emergency Service, Hospital/economics, Follow-Up Studies, Hospitalization/economics, Humans, Medication Adherence, Pharmaceutical Services/economics, Pharmacists/economics, Prescription Drugs/administration & dosage, Primary Health Care/economics, Professional Role, Quality of Life, Surveys and Questionnaires
Identifiers
Local EPrints ID: 478088
URI: http://eprints.soton.ac.uk/id/eprint/478088
ISSN: 0961-7671
PURE UUID: b2ca3a74-aad6-4f07-9def-63582fb9127d
Catalogue record
Date deposited: 21 Jun 2023 16:53
Last modified: 17 Mar 2024 04:19
Export record
Altmetrics
Contributors
Author:
James A Desborough
Author:
Tracey Sach
Author:
Debi Bhattacharya
Author:
Richard C Holland
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics